|
|||||
![]() |
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter![]() |
Ticker | Owner | Relationship | Date | Transaction | Cost ![]() |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
KNSA | Paolini John F. | CHIEF MEDICAL OFFICER | Sep 03 '24 | Sale | 26.12 | 60,692 | 1,584,991 | 52,038 | Sep 04 08:52 PM |
KNSA | Paolini John F. | Officer | Sep 03 '24 | Proposed Sale | 26.12 | 90,217 | 2,356,351 | Sep 03 05:16 PM | |
KNSA | Paolini John F. | CHIEF MEDICAL OFFICER | Jul 23 '24 | Sale | 26.32 | 22,000 | 578,966 | 47,803 | Jul 25 04:31 PM |
KNSA | Paolini John F. | CHIEF MEDICAL OFFICER | Mar 01 '24 | Sale | 21.77 | 18,844 | 410,234 | 44,892 | Mar 05 04:31 PM |
KNSA | Paolini John F. | CHIEF MEDICAL OFFICER | Feb 27 '24 | Sale | 21.03 | 10,156 | 213,581 | 44,892 | Feb 29 04:26 PM |
KNSA | Paolini John F. | CHIEF MEDICAL OFFICER | Dec 07 '23 | Sale | 17.65 | 28,600 | 504,758 | 44,892 | Dec 11 04:20 PM |
KNSA | Paolini John F. | CHIEF MEDICAL OFFICER | Sep 05 '23 | Sale | 17.53 | 400 | 7,012 | 44,892 | Sep 06 07:03 PM |
KNSA | Paolini John F. | CHIEF MEDICAL OFFICER | Jul 25 '23 | Sale | 19.14 | 29,000 | 555,160 | 41,910 | Jul 27 04:30 PM |
KNSA | Paolini John F. | CHIEF MEDICAL OFFICER | Nov 07 '22 | Sale | 15.18 | 28,357 | 430,459 | 36,335 | Nov 09 04:16 PM |
KNSA | Paolini John F. | SVP & Chief Medical Officer | Feb 19 '20 | Sale | 18.27 | 22,477 | 410,655 | 18,000 | Feb 21 04:57 PM |
KNSA | Paolini John F. | SVP & Chief Medical Officer | Feb 20 '20 | Sale | 18.96 | 9,803 | 185,832 | 18,000 | Feb 21 04:57 PM |
KNSA | Paolini John F. | SVP & Chief Medical Officer | Feb 13 '20 | Sale | 18.29 | 10,277 | 187,966 | 18,000 | Feb 18 06:05 PM |
KNSA | Paolini John F. | SVP & Chief Medical Officer | Feb 14 '20 | Sale | 18.33 | 1,039 | 19,045 | 18,000 | Feb 18 06:05 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite